Dennis F. Zagrodnik II MD, FACS

• Assistant Professor of Surgery, Wright State University Boonshoft School of
• Medicine, Dayton, Ohio

When his serum was serially inoculated into healthy marmosets allergy symptoms glands swollen purchase periactin 4 mg with amex, they too developed hepatitis allergy shots given subcutaneously purchase periactin online now. At least 5 genotypes have been identified allergy treatment for infants purchase periactin american express, each with a specific geographic distribution: genotype 1 predominates in West Africa allergy symptoms sore eyes purchase periactin without prescription, genotype 2 in Europe and the United States allergy watch order periactin no prescription, genotype 3 in parts of Asia, genotype 4 in Southeast Asia, and genotype 5 in South Africa. It is closely related to a family of animal viruses known as Circoviridae, which have not been associated with human disease. The product of the second open reading frame interferes with host nuclear factor kappa B signaling, but its role in viral replication is unknown. Some genotypes differ in sequence by greater than 50%, and genotype prevalence rates vary geographically. These viruses have been divided into 29 genotypes, with sequence divergence of greater than 30%. Sequencing of multiple isolates has demonstrated sequence divergence of 15% to 50%. None of the patients with hepatitis had a fulminant course, nor did chronic liver disease or cirrhosis develop during follow-up. Fecal-oral spread may account for the high prevalence in low-risk, healthy blood donor populations. Viremia may persist for years in both immunocompetent and immunosuppressed persons. Most infected persons have no biochemical or histologic evidence of liver disease. Most infants and children are either asymptomatic or have mild, nonspecific complaints, whereas adolescents and adults typically present with the triad of pharyngitis, fever, and lymphadenopathy. Notably, only a minority (12%) had clinical features of infectious mononucleosis, but all had lymphocytosis and 88% had splenomegaly. Liver involvement is common and is characterized by mild to moderate serum aminotransferase (88%) and alkaline phosphatase (64%) elevations with or without hepatosplenomegaly. Antiviral therapy has no effect on this syndrome, but papillotomy, with or without placement of a biliary stent, may lead to symptomatic improvement. A, A thick rind of echogenic tissue (arrows) surrounds the central portal triads and causes irregular narrowing of the intrahepatic bile ducts. D, the ampulla (arrow) is enlarged and echogenic, as viewed transversely in the caudal aspect of the pancreatic head. Ganciclovir, a guanosine nucleoside analog with a much longer intracellular half-life than that of acyclovir, has proved to be most effective. The disease is most common in late gestation, typically (in 65% of patients) in the third trimester. Mucocutaneous lesions are present in only 50% of cases, and a high index of clinical suspicion is important to ensure timely diagnosis. Of reported cases, only 50% had a rash at presentation, and 58% were diagnosed at autopsy. The transjugular route may be required because liver failure may develop rapidly, precluding percutaneous biopsy. Focal or extensive hemorrhagic or coagulative necrosis, with few inflammatory infiltrates, is seen. Intranuclear (Cowdry A type) inclusions may be identified in hepatocytes at the margins of the necrosis. Other Viruses A number of other viruses have been reported to involve the liver, ranging from mild hepatitis to fulminant liver failure. Examination of liver tissue revealed marked apoptosis, ballooning of hepatocytes, and moderate lobular lymphocytic infiltration. Liver enzyme elevations have been described, and rare cases of hepatitis with synthetic dysfunction or even fulminant liver failure have been reported in both immunocompetent and immunocompromised persons. At the edge of a necrotic zone, some hepatocytes are multinucleated, and many nuclei contain eosinophilic viral (Cowdry type A) inclusions. Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis. Herpes simplex virus hepatitis: An analysis of the published literature and institutional cases. Incidence and natural history of chemically defined varicella-zoster virus hepatitis in children and adolescents. Molecular cloning and disease association of hepatitis G virus: A transfusiontransmissible agent. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver disease. Transfusion-transmitted virus in association with hepatitis A-E viral infections in 39. Clinical outcomes of Torque teno virus-infected thalassemic patients with and without hepatitis C virus infection. The clinical manifestations of infectious mononucleosis: A report of two hundred cases. Clinical manifestations and quantitative analysis of virus load in Taiwanese children with Epstein-Barr virus-associated infectious mononucleosis. Severe cholestatic jaundice induced by Epstein-Barr virus infection in the elderly. Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection. Characterization and treatment of chronic active Epstein-Barr virus disease: A 28-year experience in the United States. Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: An analysis of treatment outcome and prognostic factors. Epstein-Barr virus hepatitis: Diagnostic value of in situ hybridization, polymerase chain reaction, and immunohistochemistry on liver biopsy from immunocompetent patients. Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis. Surveillance of Epstein-Barr virus loads in adult liver transplantation: Associations with age, sex, posttransplant times, and transplant indications. Rituximab therapy for Epstein-Barr virus-related chronic hepatitis following living donor kidney transplantation. Cytomegalovirus and human herpesvirus 6, but not human papillomavirus, are present in neonatal giant cell hepatitis and extrahepatic biliary atresia. A case report and literature review of portal vein thrombosis associated with cytomegalovirus infection in immunocompetent patients. Comparison of cytomegalovirus antigenemia and culture assays in patients on and off antiviral therapy. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children. Fulminant, acyclovirresistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman. Herpes simplex virus hepatitis in infants: Clinical outcomes and correlates of disease severity. Demographics and outcomes of severe herpes simplex virus hepatitis: A registry-based study. Disseminated varicella infection in adult renal allograft recipients: Four cases and a review of the literature. Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation. Acute fulminant hepatic failure associated with parvovirus B19 infection in an immunocompetent adult. Acute fulminant hepatitis with bone marrow failure in an adult due to parvovirus B19 infection. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. Intrahepatic longterm persistence of parvovirus B19 and its role in chronic viral hepatitis. Acute hepatitis and liver failure associated with influenza A infection in children. In addition to infection by viruses (see Chapters 78 to 83), the liver can be affected by (1) spread of bacterial or parasitic infection from outside the liver; (2) primary infection by spirochetal, protozoal, helminthic, or fungal organisms; or (3) systemic effects of bacterial or granulomatous infections. Typical findings include a scarlatiniform rash, mucosal hyperemia, hypotension, vomiting, and diarrhea. Clindamycin, in conjunction with another active agent, is recommended to interfere with bacterial toxin production. The skin lesions become discolored and even bullous, and gas gangrene spreads rapidly, leading to a high mortality rate. Jaundice may develop in up to 20% of patients with gas gangrene and is predominantly a consequence of massive intravascular hemolysis caused by an exotoxin elaborated by the bacterium. The presence of Toxic Shock Syndrome: Staphylococcus aureus or Group A Streptococci Toxic shock syndrome is a multisystem disease caused by toxic shock syndrome toxins, which are superantigens that cause T-cell activation and massive cytokine release. Originally described in association with serious infections caused by Staphylococcus aureus, this syndrome is now more frequently a complication of group A streptococcal infections, particularly necrotizing fasciitis. The clinical course can be severe, with a mortality rate approaching 20%, particularly with delayed treatment or in patients with other complications of Salmonella infection. As in typhoid fever, abnormalities in liver biochemical test results, particularly elevated serum aminotransferase levels, with or without hepatomegaly, are common. Actinomyces Actinomycosis is caused most commonly by Actinomyces israelii, a Gram-positive anaerobic bacterium. Common presenting manifestations of actinomycotic liver abscess include fever, abdominal pain, and anorexia with weight loss. Anemia, leukocytosis, an elevated erythrocyte sedimentation rate, and an elevated serum alkaline phosphatase level are nearly universal. Radiographic findings are nonspecific; multiple abscesses may be seen in both lobes of the liver. The diagnosis is based on aspiration of an abscess cavity and either visualization of characteristic sulfur granules or positive results on an anaerobic culture. Arthritis, cellulitis, erythema nodosum, and septicemia may complicate Yersinia infection. Most patients with complicated disease have an underlying comorbid condition, such as diabetes mellitus, cirrhosis, or hemochromatosis. Excess tissue iron, in particular, may be a predisposing factor because growth of the Yersinia bacterium is enhanced by iron. Listeria Hepatic invasion in adult human Listeria monocytogenes infection is uncommon. One report described 34 cases of listeriosis involving the liver, ranging from solitary to multiple abscesses and acute and granulomatous hepatitis. Predisposing conditions include immunosuppression, diabetes mellitus, and underlying liver disease, including cirrhosis, hemochromatosis, and chronic hepatitis. The diagnosis of disseminated listerial infection is based on a positive culture result from blood or isolation from an aspirate in the case of a liver abscess. The most common hepatic complication of gonococcal infection is the Fitz-Hugh­Curtis syndrome, a perihepatitis that is believed to result from direct spread of the infection from the pelvis (see later). The syndrome is distinguished from gonococcal bacteremia by a characteristic friction rub over the liver and negative blood culture results. The overall prognosis of gonococcal infection appears to be unaffected by the presence of perihepatitis. Presumed coinfection with Chlamydia trachomatis should be treated empirically (see later). Shigella and Salmonella Several case reports have described cholestatic hepatitis attributable to enteric infection with Shigella. Typhoid fever, caused by Salmonella typhi, is a systemic infection that frequently involves the liver. Elevation of serum aminotransferase levels is common, whereas the serum bilirubin level may rise in a minority of cases. Endotoxin may produce focal necrosis, a periportal mononuclear infiltrate, and Kupffer cell hyperplasia in the liver. Characteristic typhoid nodules scattered throughout the liver are the result of profound hypertrophy Legionella Legionella pneumophila, a fastidious Gram-negative bacterium, is the cause of legionnaires disease. Although pneumonia is the predominant clinical manifestation, abnormal liver biochemical test results are frequent, with elevations in serum aminotransferase levels in 50%, alkaline phosphatase levels in 45%, and bilirubin levels in 20% of cases (but usually without jaundice). Liver histologic changes include microvesicular steatosis and focal necrosis; organisms can be seen occasionally. The diagnosis is confirmed by detection of a direct fluorescence antibody in the serum or sputum or of antigen in the urine. The causative agents have been identified as the Gramnegative bacilli Bartonella henselae and, in some cases, Bartonella quintana. Bacillary angiomatosis is characterized most commonly by multiple blood-red papular skin lesions, but disseminated infection with or without skin involvement has also been described. Hepatic infection should be suspected when serum aminotransferase levels are elevated in the absence of other explanations. Hepatic infection in persons with bacillary angiomatosis may manifest as peliosis hepatis, or blood-filled cysts (see Chapter 85). For visceral infection, prolonged treatment with erythromycin or doxycycline should be administered. Histologic changes in the liver include inflammatory infiltrates, multiple microabscesses, and focal necrosis.

Efficacy of bile acid therapy for gallstone dissolution: A meta-analysis of randomized trials allergy air purifier periactin 4 mg purchase otc. In vivo kinetics of radiolucent gallstone dissolution by oral dihydroxy bile acids allergy or sinus discount periactin 4 mg free shipping. Effect of oral clarithromycin on gall-bladder motility in normal subjects and those with gall-stones allergy nose discount generic periactin uk. Prokinetic effect of alpha-adrenergic antagonist allergy forecast germany discount periactin 4 mg without a prescription, and beta-adrenergic antagonist on gall-bladder motility in humans with gall-stone disease allergy shots covered by medicare purchase periactin discount. Effect of ursodeoxycholic acid alone and ursodeoxycholic acid plus domperidone on radiolucent gallstones and gallbladder contractility in humans. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: A cohort analysis. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone. Results of extracorporeal shock wave lithotripsy of gall bladder stones in 693 patients: A plea for restriction to solitary radiolucent stones. Sonographic patterns of radiolucent gall-bladder stones for predicting successful shock-wave lithotripsy. Factors affecting gallstone recurrence after successful extracorporeal shock wave lithotripsy. Gallbladder emptying determines early gallstone clearance after shock-wave lithotripsy. Gall stone pulverisation strategy in patients treated with extracorporeal lithotripsy and follow up results of maintenance treatment with ursodeoxycholic acid. Pulverisation of calcified and non-calcified gall bladder stones: Extracorporeal shock wave lithotripsy used alone. Safety and efficacy of repeated shockwave lithotripsy of gallstones with and without adjuvant bile acid therapy. Repeated piezoelectric lithotripsy for gallstones with and without ursodeoxycholic acid dissolution: A multicenter study. A ten-year prospective study on gallbladder stone recurrence after successful extracorporeal shock-wave lithotripsy. Ten years experience with piezoelectric extracorporeal shockwave lithotripsy of gallbladder stones. Cost-effectiveness of extracorporeal shock-wave lithotripsy versus cholecystectomy for symptomatic gallstones. Randomised controlled trial of cost-effectiveness of lithotripsy and open cholecystectomy as treatments for gallbladder stones. Costs and effectiveness of extracorporeal gallbladder stone shock wave lithotripsy versus laparoscopic cholecystectomy. Extracorporeal shock wave lithotripsy for clearance of refractory bile duct stones. Electrohydraulic lithotripsy in 111 patients: A safe and effective therapy for difficult bile duct stones. Outcome of simple use of mechanical lithotripsy of difficult common bile duct stones. Predictors of unsuccessful mechanical lithotripsy and endoscopic clearance of large bile duct stones. Endoscopic treatment of retained bile-duct stones by using a balloon catheter for electrohydraulic lithotripsy without cholangioscopy. Extracorporeal shock wave lithotripsy for pancreatic and large common bile duct stones. The national mortality burden and significant factors associated with open and laparoscopic cholecystectomy: 1997-2006. The quality of cholecystectomy in Denmark: Outcome and risk factors for 20,307 patients from the national database. Modern standards for comparison of cholecystectomy with alternative treatments for symptomatic cholelithiasis with emphasis on long term relief of symptoms. Results of a survey in Ohio hospitals by the Gallbladder Survey Committee, Ohio Chapter, American College of Surgeons. The incidence and causes of death following surgery for nonmalignant biliary tract disease. Systematic review: Open, small-incision or laparoscopic cholecystectomy for symptomatic cholecystolithiasis. Bile duct injury during cholecystectomy: Causes, prevention and surgical repair in 1979. The "hidden cystic duct" syndrome and the infundibular technique of laparoscopic cholecystectomy-The danger of the false infundibulum. Single-incision laparoscopic cholecystectomy is associated with improved cosmesis scoring at the cost of significantly higher hernia rates: 1-Year results of a prospective randomized, multicenter, single-blinded trial of traditional multiport laparoscopic cholecystectomy vs. Single incision laparoscopic cholecystectomy is associated with a higher bile duct injury rate: A review and a word of caution. Operative cholangiography during routine cholecystectomy: A review of 3,012 cases. Complications of cholecystectomy: Risks of the laparoscopic approach and protective effects of operative cholangiography: A population-based study. Iatrogenic bile duct injury: A population-based study of 152,776 cholecystectomies in the Swedish Inpatient Registry. Intraoperative cholangiography and risk of common bile duct injury during cholecystectomy. Contribution of intraoperative cholangiography to incidence and outcome of common bile duct injuries during laparoscopic cholecystectomy. Complications of laparoscopic cholecystectomy in Hungary: A multicentre study of 13,833 patients. Bile duct injury during laparoscopic cholecystectomy: Results of an Italian national survey on 56,591 cholecystectomies. Risk factors for perioperative complications in patients undergoing laparoscopic cholecystectomy: Analysis of 22,953 consecutive cases from the Swiss Association of Laparoscopic and Thoracoscopic Surgery Database. Randomized clinical trial of open versus laparoscopic cholecystectomy in the treatment of acute cholecystitis. Laparoscopic and minilaparotomy cholecystectomy: A randomized trial comparing postoperative pain and pulmonary function. Comparison of early postoperative results for laparoscopic versus standard open cholecystectomy. Surgical rates and operative mortality for open and laparoscopic cholecystectomy in Maryland. Incidence and nature of bile duct injuries following laparoscopic cholecystectomy: An audit of 5913 cases. Characteristics of biliary tract complications during laparoscopic cholecystectomy: A multi-institutional study. Increased cholecystectomy rate after the introduction of laparoscopic cholecystectomy. The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients. Prevalence of asymptomatic cholelithiasis and risk of acute cholecystitis after kidney transplantation. Factors associated with postoperative complications in diabetics after biliary tract surgery. Role of prophylactic antibiotics in laparoscopic cholecystectomy: A meta-analysis. Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Controlled clinical trial comparing early with interval cholecystectomy for acute cholecystitis. Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: A meta-analysis of randomized clinical trials. Randomized trial of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Endoscopic ultrasoundguided transmural and percutaneous transhepatic gallbladder drainage are comparable for acute cholecystitis. Effect of diabetes on outcomes in patients undergoing emergent cholecystectomy for acute cholecystitis. Variation in the use of laparoscopic cholecystectomy for elderly patients with acute cholecystitis. Hepatobiliary complications in patients with human immunodeficiency virus infection. Timing of cholecystectomy for biliary pancreatitis: Do the data support current guidelines Lack of consensus on the role of endoscopic retrograde cholangiography in acute biliary pancreatitis in published meta-analyses and guidelines: A systematic review. Laparoscopy for appendicitis and cholelithiasis during pregnancy: A new standard of care. Complications of gallstones: the Mirizzi syndrome, gallstone ileus, gallstone pancreatitis, complications of "lost" gallstones. Asymptomatic cholelithiasis in children with sickle cell disease: Early or delayed cholecystectomy High incidence of cholelithiasis in older patients with homozygous betathalassemia. Increased morbidity in surgical patients undergoing secondary (incidental) cholecystectomy. Are we training our residents to perform open gall bladder and common bile duct operations Randomised trial of laparoscopic exploration of common bile duct versus postoperative endoscopic retrograde 117. Transcystic common bile duct exploration in the management of patients with choledocholithiasis. Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: Perioperative results in 200 patients. Long-term outcome of biliary reconstruction for bile duct injuries from laparoscopic cholecystectomies. Relationship between persistence of abdominal symptoms and successful outcome after cholecystectomy. Retained gallbladder/ cystic duct remnant calculi as a cause of postcholecystectomy pain. Diagnosing and treating sphincter of Oddi dysfunction: A critical literature review and reevaluation. Systematic review: Sphincter of Oddi dysfunction-non-invasive diagnostic methods and long-term outcome after endoscopic sphincterotomy. Transduodenal sphincteroplasty in the management of sphincter of Oddi dysfunction and pancreas divisum in the modern era. Cholecystectomy protects against extrahepatic bile duct cancer: Is this a result of the removal of gallstones As shown in Table 67-1, acalculous biliary pain is generally a disorder of young, predominantly female, ambulatory patients and mimics calculous biliary pain. Acute acalculous cholecystitis is typically a disease of immobilized and critically ill older men with coexisting vascular disease. Because the clinical features and prognosis of these 2 entities are quite different, they are considered separately in this chapter. Three typically asymptomatic conditions of the gallbladder-cholesterolosis, adenomyomatosis, and gallbladder polyps-are also reviewed. The localization of pain to the right hypochondrium or radiation to the right shoulder is the most specific finding for a biliary tract origin. Between attacks, the physical findings are usually normal, with the possible exception of residual upper abdominal tenderness. In comparison, the management of acalculous biliary pain represents a significant challenge. In patients with acalculous biliary pain, symptomatic improvement following cholecystectomy is more variable. In 1 series of more than 100 patients, 83% were female, and the mean age was approximately 30 years. Stimulated duodenal bile from patients with acalculous biliary pain is more dilute with respect to both bile acids and phospholipids than bile from patients with gallstones or from control women without biliary symptoms. The lower molar percentage of phospholipids supports the hypothesis that biliary phospholipids are hydrolyzed to free fatty acids, which incite inflammation. The striking preponderance of young, fertile women among patients with acalculous biliary pain closely parallels the epidemiology of cholelithiasis, suggesting that the 2 conditions have similar risk factors. Examination of a bile specimen for microlithiasis (MeltzerLyon test, discussed later) can be helpful in identifying these patients. Several studies have shown that a subset of patients with acalculous biliary pain have histologic evidence of cholesterolosis in their resected gallbladders (see later). In other patients, the resected gallbladder demonstrates significant inflammation, characteristic of chronic acalculous cholecystitis. Alternatively, the strong link between acalculous biliary pain and other functional bowel disorders suggests that visceral hypersensitivity may also contribute to biliary pain in patients with a normal gallbladder. Patients with adenomyomatosis of the gallbladder or small cholesterol polyps may have biliary pain that is relieved by cholecystectomy (see later). The 10 patients in the group randomized to no surgery continued to experience symptoms. Some are found to have a nonbiliary cause of the symptoms, and in others the pain resolves with time. As a general rule, typical biliary pain tends to resolve more reliably following cholecystectomy than do atypical symptoms such as bloating or dyspepsia.

Ethanol exposure decreases mitochondrial outer membrane permeability in cultured rat hepatocytes allergy medicine 2014 purchase 4 mg periactin with mastercard. Hepatocyte-specific hypoxiainducible factor-1 is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice allergy treatment without medication 4 mg periactin buy. Role of S-adenosylmethionine allergy medicine hallucinations cheap periactin 4 mg buy, folate allergy testing huntsville al buy 4 mg periactin visa, and betaine in the treatment of alcoholic liver disease: Summary of a symposium allergy medicine korea discount 4 mg periactin otc. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Dysregulation of glutathione synthesis during cholestasis in mice: Molecular mechanisms and therapeutic implications. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and 1427. Influence of neomycin and ingested endotoxin in the pathogenesis of choline deficiency cirrhosis in the adult rat. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: A pilot study. Chronic alcohol exposure disturbs lipid homeostasis at the adipose tissue-liver axis in mice: Analysis of triacylglycerols using high-resolution mass spectrometry in combination with in vivo metabolite deuterium labeling. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage. Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells. Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholic cirrhosis. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition. Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease. Histone modifications and alcohol-induced liver disease: Are altered nutrients the missing link Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury. The epidemiology and clinical characteristics of patients with newly diagnosed alcohol-related liver disease: Results from population-based surveillance. Alcohol use disorders in the elderly: A brief overview from epidemiology to treatment options. Alcohol use in pregnancy: Insights in screening and intervention for the clinician. Blood alcohol is the best indicator of hazardous alcohol drinking in young adults and working-age patients with trauma. Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption. Continuous objective monitoring of alcohol use: Twenty-first century measurement using transdermal sensors. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Pseudo-Budd-Chiari syndrome: Decompensated alcoholic liver disease mimicking hepatic venous outflow obstruction. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis-A randomised clinical trial. Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Long-term prognosis of patients with alcoholic liver cirrhosis: A 15-year follow-up study of 100 Norwegian patients admitted to one unit. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. The rate of decompensation and clinical progression of disease in people with cirrhosis: A cohort study. Risk factors, sequential organ failure assessment and Model for End-Stage Liver Disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Cirrhotic patients in the medical intensive care unit: Early prognosis and long-term survival. Behavioral counseling after screening for alcohol misuse in primary care: A systematic review and meta-analysis for the U. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: Randomized, double-blind controlled study. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: A randomized multicenter controlled trial. Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: A randomized 12-month trial. Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis. Combining steroids with enteral nutrition: A better therapeutic strategy for severe alcoholic hepatitis Infection in patients with severe alcoholic hepatitis treated with steroids: Early response to therapy is the key factor. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease. Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: A randomized trial. The characteristic feature is diffuse macrovesicular steatosis without significant necroinflammation or fibrosis. Lobular inflammation consists of neutrophils, lymphocytes, and other mononuclear cells. Similarly, surgeries that lead to rapid and extreme intestinal malabsorption and weight loss, such as extensive small bowel resection, biliopancreatic diversion, or jejunoileal bypass (see Chapter 8), have been associated with hepatic steatosis. Medications including amiodarone, valproic acid, methotrexate, tamoxifen, glucocorticoids, certain antiretrovirals, and tetracyclines have also been implicated, as have systemic conditions such as Wilson disease, abetalipoproteinemia, and lipodystrophy. The 2-hit hypothesis states that dysregulation of fatty acid metabolism leads to steatosis, which is associated with several cellular adaptations and altered signaling pathways that render hepatocytes vulnerable to a second hit. The second insult may be 1 or more environmental or genetic perturbations that cause hepatocyte necrosis and inflammation. In a minority of cases, incompletely defined factors activate a fibrogenic cascade that leads eventually to cirrhosis. Bile acids absorbed from the distal ileum bind to these nuclear hormone receptors. Fatty acid metabolism is under tight regulatory control by catecholamines, glucagon, growth hormone, and insulin. Obesity in humans Steatohepatitis Although insulin resistance and hyperinsulinemia are pivotal to the development of steatosis, consensus is lacking on the subsequent insults that lead to steatohepatitis and fibrosis in some patients. Isolated steatosis may be considered an adaptive mechanism designed to mitigate the effects of long-chain saturated fatty acids within the liver. If the protective processes are overwhelmed or faulty, lipotoxicity can develop, potentially activating numerous signaling pathways in the liver and resulting in hepatocyte apoptosis and stellate cell activation. The precise signaling pathways are still being uncovered, but several key pathways have been defined. Autophagy may also influence hepatic stellate cells and protect against apoptosis. The exact interplay of all the proposed pathogenic factors remains to be elucidated. Hepatomegaly is commonly seen but often is difficult to appreciate on physical examination because of obesity. Stigmata of chronic liver disease, such as splenomegaly, spider telangiectasias, and ascites, are limited to those patients with cirrhosis. Proposed pathogenesis of nonalcoholic steatohepatitis integrating obesity and insulin resistance with bile acid metabolism, lipotoxicity, autophagy, endoplasmic reticulum stress, apoptosis, and hepatic progenitor cell transformation and stellate cell activation resulting in hepatic steatosis, necroinflammation, and fibrosis (see text for details). Liver biopsy is an invasive procedure associated with rare but severe complications, including hemorrhage and even death, and undertaking liver biopsies in 20% to 30% of the general population is not feasible (see Chapter 21). Advanced imaging techniques as well as laboratory tests and scoring systems have been studied as a means of identifying high-risk patients who should undergo liver biopsy or as potential noninvasive markers of steatohepatitis or fibrosis. The most studied and widely available has been transient elastography (Fibroscan; Echosens, Paris, France), which uses a lowamplitude shear wave that propagates through the liver parenchyma. The speed at which the wave moves is correlated with liver stiffness, measured in kilopascals. Advantages of this noninvasive technique include relative simplicity, ease of use, and patient acceptance. Most patients are evaluated because of elevated serum aminotransferase levels and/or hepatomegaly. This technology measures the velocity of a short-duration, high-intensity acoustic pushing pulse in the liver. Biomarkers and Scoring Systems Progress has been made in developing simple, noninvasive, and quantitative tests to estimate the presence and degree of steatohepatitis or hepatic fibrosis. Comparison of the accuracy of these tests in terms of positive and negative predictive values generally has demonstrated that the more complex and expensive tests. These tests are best at predicting either absent or advanced fibrosis (cirrhosis) and are less helpful for estimating intermediate stages of fibrosis. Therefore, patients with a score in this range would need a liver biopsy for accurate staging. One in 4 scores is indeterminate, and a liver biopsy is therefore required for accurate staging. The prognosis in patients with steatosis in the absence of hepatocyte necrosis and fibrosis clearly is favorable, with little potential for histologic or clinical progression. Isolated fatty liver rarely if ever progresses to cirrhosis and is not associated with an increased risk of death compared with the general population. The 5-year survival rate of patients with alcoholic hepatitis is only 50% to 75% because of the large proportion of patients (>50%) in whom cirrhosis and its complications develop. Cardiovascular disease has been shown to be the primary cause of death in this population. Clinical trials to date have been marked by small numbers of patients as well as varying inclusion criteria and end points. Although improvements in metabolic parameters, liver enzyme levels, or steatosis on imaging are readily determined in clinical trials, histologic improvement in steatosis, inflammation, and fibrosis is the ultimate goal of treatment. Multiyear trials are rarely seen; most trials have been 6 to 12 months in duration. Lifestyle Modification Lifestyle modification is often divided into calorie reduction, with a goal of weight loss, macronutrient modification, and physical activity, including aerobic and resistance activity. Most studies of calorie restriction include an exercise component, making it difficult to assess whether diet or exercise is more beneficial. Intensive nutritional counseling may lead to sustained weight loss and significant histologic improvement in some patients. A metaanalysis of 9 studies with a total of 355 patients demonstrated that omega-3 supplementation improves hepatic steatosis, although no histologic data were available. In large retrospective studies, caffeinated coffee intake has been found to have a protective effect against hepatic fibrosis in alcoholic liver disease118 as well as chronic hepatitis C. The effects of "light" or "moderate" alcohol intake are controversial, with conflicting results in several cross-sectional and retrospective studies. Current expert opinion recommends against "even light alcohol consumption" in the absence of prospective data. A reduction in the intake of high-fructose corn syrup and an increase in the intake of omega-3 fatty acids and caffeinated coffee are intriguing adjuvants to a multidisciplinary approach that includes caloric reduction and increased physical activity.

Subsequent data have indicated that patients with asymptomatic disease have an excellent medium- and long-term outcome allergy forecast illinois effective periactin 4 mg. The implementation of routine anticoagulation has been accompanied by a marked improvement in outcome allergy treatment breastfeeding cheap periactin line. In symptomatic patients allergy shots permanent 4 mg periactin purchase mastercard, venous lesions amenable to percutaneous angioplasty should be investigated and treated accordingly allergy testing lexington ky 4 mg periactin order free shipping. Anticoagulation therapy allergy testing johns hopkins order generic periactin from india, given to 85% of patients, was associated with a bleeding rate of 17%. Portal hypertension was the main cause of bleeding, followed by intracranial hemorrhage. The rate of bleeding-related deaths was 2%, similar to that in patients anticoagulated for venous thromboembolism in general. In a report from China, percutaneous recanalization was associated with excellent rates of technical success (95%) and 10-year survival (73%). Portal cavernoma is characterized by the disappearance of the normal portal vein and its replacement by a network of portoportal collaterals. When a portal cavernoma is found in a child, a congenital malformation should also be considered. Chronic liver disease and abdominal malignancy are each found in about one third of patients. Furthermore, one third of the patients with a local factor also had a systemic risk factor for thrombosis. The thrombotic occlusion is extremely variable in degree (partial or complete) and extent (involving only the portal vein or one of its two branches or the splenic or superior mesenteric vein [or both]). By contrast, an infected thrombus ab initio is characteristic of septic pylephlebitis. Hepatic blood flow is maintained because of increased arterial blood flow and rapid opening of portoportal collaterals that permit blood flow around the obstructed segment of the portal vein. When the thrombus is less than 30 days old, unenhanced images appear as hyperattenuated material. When the thrombus is limited to a branch of the portal vein, there is increased enhancement at the arterial phase in the liver corresponding to the thrombosed branch. A small amount of ascitic fluid may be detected on imaging in the absence of intestinal ischemia. Signs of multiorgan dysfunction, acidosis, or lactic acidemia are major indicators of severe intestinal involvement requiring surgical exploration. Evidence for malignant obstruction includes demonstration of a tumor in the vicinity of the portal vein, enhancement of endoluminal material in the arterial phase, or neoplastic cells on biopsy specimens of the endoluminal material. Blood counts may show nonspecific changes, mostly reflecting the systemic inflammatory response syndrome (which may be marked) or the underlying blood disease. Liver biochemical test results usually show no alterations or minor transient changes. Dilated veins are seen in the porta hepatis, particularly in the gallbladder wall (arrow). The extension of the thrombus, and the type of underlying prothrombotic condition, must be taken into account when a decision is made to prolong anticoagulation. Early initiation of anticoagulation therapy is likely critical to preventing this dreaded complication. Plasma levels of coagulation factors and inhibitors are decreased,52 and these alterations are increased by portosystemic shunting but ameliorated by portal reperfusion. Liver biochemical test levels are usually normal or near normal, although plasma levels of coagulation factors and inhibitors can be moderately decreased. Conversely, patients with cholangiopathy often have normal liver biochemical test results. Portoportal collaterals arise from preexisting veins in the porta hepatis and pancreas. Collaterals that emanate from the bile duct veins can produce deformity of the bile ducts, a condition named portal hypertensive biliopathy or portal cholangiopathy. In the absence of preexisting liver disease, liver structure and function remain normal because the cavernoma restores, at least partially, the abolished portal venous inflow to the liver, while hepatic arterial inflow increases. The portal vein bifurcation is not visible and is replaced by serpiginous structures that enhance during the portal venous phase and represent the cavernoma (arrow). Structures that enhance in the wall of the bile duct correspond to biliary veins (arrowhead). In rare patients, the appearance is that of a solid mass that causes biliary obstruction. The differential feature is the enhancement of the "pseudotumor" in the portal phase of the study. In other patients, the decision regarding long-term anticoagulation should be made on an individual basis, taking into account the prothrombotic potential of the underlying condition and the likelihood of adherence to therapy. When feasible, a meso-Rex shunt has provided excellent results in children, in whom it is the preferred option,53 but experience in adults is lacking (see Chapter 92). Mortality in patients with a portal cavernoma is related mostly to the underlying condition, not to the complications of portal hypertension. The type of anticoagulant (low molecular weight heparin or an oral vitamin K antagonist) and duration of treatment to achieve an optimal result remain to be studied. On the other hand, extension to the superior mesenteric vein may induce intestinal ischemia. With Chapter 85 VascularDiseasesoftheLiver 1401 venous pressure gradient (see Chapter 92) is typically normal but may be increased because the site of the block is not always exclusively presinusoidal. Nevertheless, some patients have come to liver transplantation because of advanced liver disease, often with a misdiagnosis of cirrhosis. On the other hand, obliterative portal venopathy can be found in patients in whom features of portal hypertension are inconspicuous or lacking. Abnormalities of the serum bilirubin, albumin, and coagulation factor levels are common, but marked changes are unusual. On abdominal imaging, intrahepatic portal venous abnormalities (reduced caliber, occlusive thrombosis, and lack of visibility), focal nodular hyperplasia-like nodules, and perfusion disorders are common. The principal distinctions are the absence of a cause for cirrhosis and preserved liver function despite severe portal hypertension. Portal hypertension can be managed as in patients with cirrhosis (see Chapter 92). Short- and medium-term outcomes appear to be good and much better than those in patients with cirrhosis. In the long term, however, advanced liver disease may complicate the course of 10% of patients. Sclerotic portal tracts devoid of patent venules, irregularly distributed in a noncirrhotic parenchyma, are seen. Small regenerative nodules within the acini are surrounded by atrophic hepatocytes in a nonfibrous parenchyma. Slender bridging septa are common and are prominent in the related entity of incomplete septal fibrosis. Scattered, less well-defined areas of regenerative changes of hepatocytes are common. The lesions described constitute a block to intrahepatic portal flow that causes portal hypertension. In practice, the diagnostic criteria are clinical, rather than histologic, and have therefore produced some confusion (see later). Sinusoidal endothelial cells appear to be more sensitive than hepatocytes to the toxic effects of the transformed drugs, possibly related to lower stores of glutathione in sinusoidal endothelial cells. Several arguments suggest that endothelialitis related to graft rejection is the cause of this particular entity (see Chapter 97). Endothelial damage in the central veins manifests as a rounding of the cells, followed by subendothelial edema and hemorrhage, producing the characteristic eccentric narrowing of the lumen. Central vein damage is more marked in areas where sinusoidal dilatation is more severe. Characteristically the periportal area, portal tracts, and portal vessels remain intact. A, Massive centrilobular and mid-lobule congestion with obliteration of a terminal hepatic vein (arrowhead) is seen. Gross changes in the flow pattern in the portal and hepatic veins, as well as hepatic arteries, are nonspecific. Serum bilirubin or aminotransferase elevations are major determinants of immediate prognosis. Portosystemic shunting explains why some patients present with hepatic encephalopathy, primary pulmonary arterial hypertension, or hypoxemia due to hepatopulmonary syndrome (see Chapter 94). Portal blood deprivation explains the liver hyperarterialization and regenerative changes, including nodular regenerative hyperplasia and regenerative macronodules, that have been reported as adenomas or focal nodular hyperplasia. There are anecdotal reports of hepatocellular carcinoma, although causality is difficult to ascertain. The spectrum of neurologic involvement has ranged from changes in brain imaging and subtle abnormalities on neuropsychological testing to learning disabilities and overt encephalopathy. Their characteristics can be typical of benign regenerative macronodules or focal nodular hyperplasia. Completely benign nodules can have a heterogeneous appearance and not remain stable in size or features. Shunt closure can be performed with percutaneous interventional radiology techniques or surgically. The possibility of closing a shunt should limit the need for liver transplantation. In a patient with regenerative macronodules, surgical resection or liver transplantation should not be considered unless hepatocellular carcinoma or marked dysplasia has been demonstrated unequivocally. Moreover, compensatory hypertrophy of the remnant liver following resection may be considerably slower than in the absence of a portosystemic shunt. A more physiologic term would be hypoxic hepatitis, because the primary cause of this syndrome is tissue hypoxia, which may be the result of hypoperfusion from cardiac failure, systemic hypoxemia from respiratory failure, or increased oxygen requirements from sepsis. Ischemic hepatitis is probably the most commonly encountered form of vascular liver disease. Hypotension often is clinically apparent as a result of acute myocardial infarction, severe heart failure, or sepsis but may be less obvious following a transient arrhythmia or silent coronary ischemic event. The presence of heart failure significantly increases the likelihood that a drop in cardiac output from any cause will result in ischemic hepatitis. More than 80% of cases of ischemic hepatitis occur in the setting of heart failure. Clinical Features and Diagnosis Ischemic hepatitis often is first considered when extreme serum aminotransferase elevations are detected in a patient hospitalized for problems not primarily associated with the liver. Findings on physical examination are usually dominated by the underlying precipitating medical condition. Laboratory studies show extreme elevations of the aminotransferase levels (>3000 U/L). Serum creatinine and blood urea nitrogen levels are often elevated because of acute tubular necrosis. Characteristically, serum aminotransferase levels peak 1 to 3 days after the hemodynamic insult and return to normal within 7 to 10 days. The differential diagnosis of this type of severe acute injury includes acute hepatitis caused by viral infections, autoimmunity, toxins, and medications (see Chapter 73). This low-power photomicrograph demonstrates centrilobular necrosis, loss of hepatocytes, and sinusoidal congestion with red blood cells, but only a scant inflammatory infiltrate. In the most severely affected patients, ischemic hepatitis is just one manifestation of multiorgan failure and signals a poor prognosis. Fulminant hepatic failure resulting from ischemic hepatitis is uncommon but is more likely to occur when chronic heart failure or cirrhosis is also present. The overall prognosis depends primarily on the severity of the underlying predisposing condition, not the severity of the liver disease. No specific therapy exists for ischemic hepatitis, and treatment is directed at improving cardiac output and systemic oxygenation. The result is centrilobular congestion and sinusoidal edema that further decrease oxygen delivery. The injurious effects of superimposed ischemic hepatitis are common in these patients. Sinusoidal hypertension and congestion can lead to the development of ascites, with a characteristically high serum-ascites albumin gradient and a high protein concentration (see Chapter 93). Chapter 85 VascularDiseasesoftheLiver 1405 Clinically, the symptoms and signs of heart failure are the predominant features. The liver may be pulsatile if tricuspid regurgitation is present, and hepatojugular reflux is often apparent on compression over the liver. Spider telangiectasias and varices are usually not present, and variceal bleeding caused by congestive hepatopathy alone does not occur. Mild elevation of the serum bilirubin level (to < 3 mg/dL) is common, and jaundice is seen in fewer than 10% of patients, occurring in those with severe or acute heart failure. Liver test results improve slowly or normalize with effective therapy of the underlying heart failure. Centrilobular necrosis, consistent with ischemic hepatitis, is frequent in liver biopsy specimens that show congestive hepatopathy and usually correlates with recent hypotension. The distribution of fibrosis throughout the liver is highly variable and correlates with focal sinusoidal thrombosis, with obliteration of central and portal veins that leads in turn to localized ischemia, parenchymal extinction, and fibrosis. Occasionally, paracentesis may be needed to alleviate tense ascites, but therapy is generally directed at improving cardiac disease.

Discount 4 mg periactin with amex. Beer Allergy - Beer Allergy Symptoms and Complications.

References

• Gomez RG, Castanheira AC, McAninch JW: Gunshot wounds to the male external genitalia, J Urol 150:1147n1149, 1993.
• Annual smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 1997-2001.
• Yamamoto K, Ikeda U, Furuhashi K et al. The coagulation system is activated in idiopathic cardiomyopathy. J Am Coll Cardiol. 1995;25:1634-1640.
• Dallemagne B, Weerts JM, Jehaes C, et al: Laparoscopic Nissen fundoplication: Preliminary report. Surg Laparosc Endosc 1:138, 1991.
• Lee H, Kim HA. Nystagmus in SCA territory cerebellar infarction: pattern and a possible mechanism. J Neurol Neurosurg Psychiatry 2013;84(4):446-51.